Duration effects in contingency management treatment of methamphetamine disorders

Addictive Behaviors

Volumn 38, Issue 9, 2013, Pages 2455-2462

  Roll, John M ^a   Chudzynski, Joy ^b   Cameron, Jennifer M ^a   Howell, Donelle N ^a   McPherson, Sterling ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contingency management

Indexed keywords

METHAMPHETAMINE;

ABSTINENCE; ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL EFFECTIVENESS; CONTINGENCY MANAGEMENT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AMPHETAMINE-RELATED DISORDERS; ANALYSIS OF VARIANCE; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOTHERAPY, GROUP; REINFORCEMENT SCHEDULE; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE DETECTION; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84878368574     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2013.03.018     Document Type: Article

References (50)

1. Bigelow G.E., Stitzer M.L., Griffiths R.R., Liebson I.A. Contingency management approaches to drug self-administration and drug abuse: Efficacy and limitations. Addictive Behaviors 1981, 6(3):241-252.
2. Budney A.J., Higgins S.T., Radonovich K.J., Novy P.L. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. Journal of Consulting and Clinical Psychology 2000, 68(6):1051-1061.
3. Childress A.R., McLellan A.T., O'Brien C.P. Behavioral therapies for substance abuse. The International Journal of the Addictions 1985, 20(6-7):947-969.
4. Corby E.A., Roll J.M., Ledgerwood D.M., Schuster C.R. Contingency management interventions for treating the substance abuse of adolescents: A feasibility study. Experimental and Clinical Psychopharmacology 2000, 8(3):371-376.
5. Crowley T.J. Research on contingency management of drug dependence: Clinical implications and future directions. Motivating behavior change among illicit-drug abusers: Research on contingency management interventions 1999, 345-370. American Psychological Association, Washington, D.C. K. S. T. S. Higgins (Ed.).
6. Dallery J., Silverman K., Chutuape M.A., Bigelow G.E., Stitzer M.L. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: Effects of reinforcer magnitude. Experimental and Clinical Psychopharmacology 2001, 9(3):317-325.
7. Glosser D.S. The use of token economy to reduce illicit drug use among methadone maintenance clients. Addictive Behaviors 1983, 8(2):93-104.
8. Griffith J.D., Rowan-Szal G.A., Roark R.R., Simpson D.D. Contingency management in outpatient methadone treatment: A meta-analysis. Drug and Alcohol Dependence 2000, 58(1-2):55-66.
9. Higgins S.T. The influence of alternative reinforcers on cocaine use and abuse: A brief review. Pharmacology, Biochemistry, and Behavior 1997, 57(3):419-427.
10. Higgins S.T., Bickel W.K., Hughes J.R. Influence of an alternative reinforcer on human cocaine self-administration. Life Sciences 1994, 55(3):179-187.
11. Higgins S.T., Budney A.J., Bickel W.K., Foerg F.E., Donham R., Badger G.J. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Archives of General Psychiatry 1994, 51(7):568-576.
12. Higgins S.T., Silverman K. Motivating behavior change among illicit-drug abusers: Research on contingency management interventions 1999, American Psychological Association, Washington, DC.
13. Higgins S.T., Stitzer M.L., Bigelow G.E., Liebson I.A. Contingent methadone delivery: Effects on illicit-opiate use. Drug and Alcohol Dependence 1986, 17(4):311-322.
14. Iguchi M.Y., Stitzer M.L., Bigelow G.E., Liebson I.A. Contingency management in methadone maintenance: Effects of reinforcing and aversive consequences on illicit polydrug use. Drug and Alcohol Dependence 1988, 22(1-2):1-7.
15. Jones H.E., Haug N., Silverman K., Stitzer M., Svikis D. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug and Alcohol Dependence 2001, 61(3):297-306.
16. Kirby K.C., Marlowe D.B., Festinger D.S., Lamb R.J., Platt J.J. Schedule of voucher delivery influences initiation of cocaine abstinence. Journal of Consulting and Clinical Psychology 1998, 66(5):761-767.
17. Lapham S.C., Stout R., Laxton G., Skipper B.J. Persistence of addictive disorders in a first-offender driving while impaired population. Archives of General Psychiatry 2011, 68(11):1151-1157. (Epub 2011 Jul 4). 10.1001/archgenpsychiatry.2011.78.
18. Leal J., Galanter M. The use of contingency contracting to improve outcome in methadone maintenance. Substance Abuse 1995, 16:155-167.
19. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.J., Higgins S.T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101(2):192-203.
20. McNamara C., Schumacher J.E., Milby J.B., Wallace D., Usdan S. Prevalence of nonpsychotic mental disorders does not affect treatment outcome in a homeless cocaine-dependent sample. The American Journal of Drug and Alcohol Abuse 2001, 27(1):91-106.
21. Peirce J.M., Petry N.M., Stitzer M.L., Blaine J., Kellogg S., Satterfield F., et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Drug Abuse Treatment Clinical Trials Network study. Archives of General Psychiatry 2006, 63(2):201-208.
22. Petry N.M. Discounting of delayed rewards in substance abusers: Relationship to antisocial personality disorder. Psychopharmacology 2002, 162(4):425-432.
23. Petry N.M., Martin B. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. Journal of Consulting and Clinical Psychology 2002, 70(2):398-405.
24. Petry N.M., Peirce J.M., Stitzer M.L., Blaine J., Roll J.M., Cohen A., et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A national drug abuse treatment clinical trials network study. Archives of General Psychiatry 2005, 62(10):1148-1156.
25. Prendergast M., Podus D., Finney J., Greenwell L., Roll J. Contingency management for treatment of substance use disorders: A meta-analysis. Addiction 2006, 101(11):1546-1560.
26. Preston K.L., Umbricht A., Wong C.J., Epstein D.H. Shaping cocaine abstinence by successive approximation. Journal of Consulting and Clinical Psychology 2001, 69(4):643-654.
27. Rawson R.A., Gonzales R., Brethen P. Treatment of methamphetamine use disorders: An update. Journal of Substance Abuse Treatment 2002, 23(2):145-150.
28. Rawson R.A., Shoptaw S.J., Obert J.L., McCann M.J., Hasson A.L., Marinelli-Casey P.J., et al. An intensive outpatient approach for cocaine abuse treatment. The Matrix model. Journal of Substance Abuse Treatment 1995, 12(2):117-127.
29. Reilly M.P., Roll J.M., Downey K.K. Impulsivity and voucher versus money preference in polydrug-dependent participants enrolled in a contingency-management-based substance abuse treatment program. Journal of Substance Abuse Treatment 2000, 19(3):253-257.
30. Robles E., Stitzer M.L., Strain E.C., Bigelow G.E., Silverman K. Voucher-based reinforcement of opiate abstinence during methadone detoxification. Drug and Alcohol Dependence 2002, 65(2):179-189.
31. Roll J.M., Higgins S.T. A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. Drug and Alcohol Dependence 2000, 58(1-2):103-109.
32. Roll J.M., Higgins S.T., Badger G.J. An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. Journal of Applied Behavior Analysis 1996, 29(4):495-504.
33. Roll J.M., Higgins S.T., Steingard S., McGinley M. Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: A feasibility study. Experimental and Clinical Psychopharmacology 1998, 6(2):157-161.
34. Roll J.M., Petry N.M., Stitzer M.L., Brecht M.L., Peirce J.M., McCann M.J., et al. Contingency management for the treatment of methamphetamine use disorders. The American Journal of Psychiatry 2006, 163(11):1993-1999.
35. Roll J.M., Reilly M.P., Johanson C.E. The influence of exchange delays on cigarette versus money choice: A laboratory analog of voucher-based reinforcement therapy. Experimental and Clinical Psychopharmacology 2000, 8(3):366-370.
36. Schafer J.L., Graham J.W. Missing data: Our view of the state of the art. Psychological Methods 2002, 7(2):147-177.
37. Schmitz J.M., Rhoades H.M., Elk R., Creson D., Hussein I., Grabowski J. Medication take-home doses and contingency management. Experimental and Clinical Psychopharmacology 1998, 6(2):162-168.
38. Schwartz B., Lauderdale R.M., Montgomery M.L., Burch E.A., Gallant D.M. Immediate versus delayed feedback on urinalyses reports for methadone maintenance patients. Addictive Behaviors 1987, 12(3):293-295.
39. Shaner A., Roberts L.J., Eckman T.A., Tucker D.E., Tsuang J.W., Wilkins J.N., et al. Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence. Psychiatric Services 1997, 48(6):807-810.
40. Sigmon S.C., Steingard S., Badger G.J., Anthony S.L., Higgins S.T. Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: A feasibility study. Experimental and Clinical Psychopharmacology 2000, 8(4):509-517.
41. Silverman K., Chutuape M.A., Bigelow G.E., Stitzer M.L. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: Effects of reinforcement magnitude. Psychopharmacology 1999, 146(2):128-138.
42. Silverman K., Svikis D., Wong C.J., Hampton J., Stitzer M.L., Bigelow G.E. A reinforcement-based therapeutic workplace for the treatment of drug abuse: Three-year abstinence outcomes. Experimental and Clinical Psychopharmacology 2002, 10(3):228-240.
43. Stein M.D., Solomon D.A., Herman D.S., Anthony J.L., Ramsey S.E., Anderson B.J., et al. Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users. Archives of General Psychiatry 2004, 61(2):152-159.
44. Stitzer M.L., Bigelow G.E. Contingent reinforcement for reduced breath carbon monoxide levels: Target-specific effects on cigarette smoking. Addictive Behaviors 1985, 10(4):345-349.
45. Stitzer M.L., Bigelow G.E., Liebson I. Reducing benzodiazepine self-administration with contingent reinforcement. Addictive Behaviors 1979, 4(3):245-252.
46. Stitzer M.L., Higgins S.T. Behavioral treatment of drug and alcohol abuse. Psychopharmacology: The fourth generation of progress 1995, 1807-1819. Raven Press Ltd., New York. F.E. Bloom, D.J. Kupfer (Eds.).
47. Stitzer M.L., Rand C.S., Bigelow G.E., Mead A.M. Contingent payment procedures for smoking reduction and cessation. Journal of Applied Behavior Analysis 1986, 19(2):197-202.
48. Substance Abuse and Mental Health Services Administration Treatment Episode Data Set (TEDS): 1994-1999. National Admissions to Substance Abuse Treatment Services 2001, Office of Applied Studies, Rockville, MD.
49. Substance Abuse and Mental Health Services Administration Summary of findings from the 2001 National Household Survey on Drug Abuse: Volume II. Technical appendices and selected data tables 2002, Office of Applied Studies, Rockville, MD.
50. Twisk J.W.R. Applied longitudinal data analysis for epidemiology: A practical guide 2003, Cambridge University Press, Cambridge, UK.